Association between Serum Potassium with Risk of Onset and Visual Field Progression in Patients with Primary Angle Close Glaucoma: A Cross-Sectional and Prospective Cohort Study.


Journal

Oxidative medicine and cellular longevity
ISSN: 1942-0994
Titre abrégé: Oxid Med Cell Longev
Pays: United States
ID NLM: 101479826

Informations de publication

Date de publication:
2022
Historique:
received: 06 04 2022
accepted: 04 06 2022
entrez: 5 7 2022
pubmed: 6 7 2022
medline: 7 7 2022
Statut: epublish

Résumé

Evidence suggests that ion metabolism may be associated with oxidative stress in the ocular tissue in glaucoma patients. This study is aimed at determining whether serum ion levels are associated with the onset and/or visual field (VF) progression of PACG. A total of 265 PACG and 166 healthy subjects were included in the cross-sectional study. Meanwhile, 265 subjects with PACG were followed up every six months for at least two years in the cohort study. All subjects were evaluated for serum concentrations of ions (calcium, phosphorus, potassium (K

Identifiants

pubmed: 35783194
doi: 10.1155/2022/2275171
pmc: PMC9246612
doi:

Substances chimiques

Potassium RWP5GA015D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2275171

Informations de copyright

Copyright © 2022 Yichao Qiu et al.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Front Aging Neurosci. 2021 Dec 24;13:756186
pubmed: 35002675
EPMA J. 2021 Sep 13;12(4):403-433
pubmed: 34539937
CNS Neurol Disord Drug Targets. 2018;17(4):255-260
pubmed: 29422007
JAMA Ophthalmol. 2014 Dec;132(12):1414-20
pubmed: 25171442
Nat Genet. 2010 Oct;42(10):906-9
pubmed: 20835238
EPMA J. 2020 Apr 13;11(2):177-196
pubmed: 32547650
Int J Nanomedicine. 2020 Aug 06;15:5745-5765
pubmed: 32821099
Glia. 2002 May;38(3):256-67
pubmed: 11968063
J Membr Biol. 2013 Feb;246(2):167-75
pubmed: 23135060
Invest Ophthalmol Vis Sci. 2011 Nov 07;52(12):8672-9
pubmed: 21908580
J Physiol. 1990 Dec;431:343-64
pubmed: 1983120
Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2750-6
pubmed: 12766083
Am J Ophthalmol. 2020 Sep;217:55-67
pubmed: 32360861
Curr Opin Ophthalmol. 2009 Mar;20(2):73-8
pubmed: 19240538
Curr Opin Ophthalmol. 2007 Mar;18(2):110-4
pubmed: 17301611
Exp Eye Res. 2019 Oct;187:107728
pubmed: 31323276
Br J Ophthalmol. 2022 Jan 11;:
pubmed: 35017157
Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5251-8
pubmed: 19516005
Invest Ophthalmol Vis Sci. 1979 Nov;18(11):1139-50
pubmed: 116968
Prog Brain Res. 2015;220:127-53
pubmed: 26497788
Free Radic Biol Med. 2004 Sep 15;37(6):803-12
pubmed: 15384194
J Cereb Blood Flow Metab. 2013 Nov;33(11):1685-95
pubmed: 23963372
Oxid Med Cell Longev. 2017;2017:2817252
pubmed: 28270908
Am J Med. 2003 Jun 1;114(8):638-46
pubmed: 12798451
Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3650-61
pubmed: 15452073
Clin J Am Soc Nephrol. 2015 Jun 5;10(6):1050-60
pubmed: 24721891
Vestn Oftalmol. 2018;134(2):4-11
pubmed: 29771879
Acta Ophthalmol. 2016 May;94(3):217-25
pubmed: 26119516
Semin Nephrol. 2013 May;33(3):229-36
pubmed: 23953800
Prog Retin Eye Res. 2017 Mar;57:26-45
pubmed: 28039061
Prog Retin Eye Res. 2012 Nov;31(6):702-19
pubmed: 22871543
Front Genet. 2018 Oct 24;9:488
pubmed: 30405695
Invest Ophthalmol Vis Sci. 1999 Jun;40(7):1404-17
pubmed: 10359322
Invest Ophthalmol Vis Sci. 2011 Oct 28;52(11):8407-12
pubmed: 21917940
Arch Ophthalmol. 2005 Apr;123(4):458-63
pubmed: 15824217
JAMA. 2014 May 14;311(18):1901-11
pubmed: 24825645
EPMA J. 2021 Nov 02;12(4):659-675
pubmed: 34745391
Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):41
pubmed: 32203982
Br J Pharmacol. 2006 Jan;147 Suppl 1:S63-71
pubmed: 16402122
EPMA J. 2019 Jun 11;10(3):261-271
pubmed: 31462943
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):682-689
pubmed: 28134964
Science. 2002 Feb 8;295(5557):1077-9
pubmed: 11834836
Nature. 2002 Nov 28;420(6914):414-8
pubmed: 12459783
J Trace Elem Med Biol. 2018 Jan;45:150-155
pubmed: 29173472
Ophthalmology. 2005 Oct;112(10):1661-9
pubmed: 16111758
Oxid Med Cell Longev. 2020 Aug 05;2020:2701539
pubmed: 32831992
J Comp Neurol. 2002 Oct 28;452(4):381-91
pubmed: 12355420

Auteurs

Yichao Qiu (Y)

Clinical Laboratory, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Jiaojiao Wei (J)

Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Jian Yu (J)

Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Yingzhu Li (Y)

Clinical Laboratory, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Mingxi Shao (M)

Clinical Laboratory, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Jun Ren (J)

Clinical Laboratory, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Wenjun Cao (W)

Clinical Laboratory, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.
Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.
NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai 200031, China.
Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai 200031, China.

Shengjie Li (S)

Clinical Laboratory, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.
Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Xinghuai Sun (X)

Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.
NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai 200031, China.
Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai 200031, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH